ASCO 2019

Sunitinib molecule. Image credit: National Library of Medicine, National Institutes of Health

NCI Pediatric MATCH Study Shows High Rate of Targetable Molecular Alterations in Tumor Specimens

By

Susan Moench, PhD, PA-C

May 21, 2019

A high percentage of patients with CNS tumors had disease characterized by an actionable molecular alteration.